120 related articles for article (PubMed ID: 11498770)
1. Growth of human melanoma xenografts is suppressed by systemic angiostatin gene therapy.
Rodolfo M; Catò EM; Soldati S; Ceruti R; Asioli M; Scanziani E; Vezzoni P; Parmiani G; Sacco MG
Cancer Gene Ther; 2001 Jul; 8(7):491-6. PubMed ID: 11498770
[TBL] [Abstract][Full Text] [Related]
2. Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA.
Tanaka T; Cao Y; Folkman J; Fine HA
Cancer Res; 1998 Aug; 58(15):3362-9. PubMed ID: 9699667
[TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic gene therapy for hepatocellular carcinoma using angiostatin gene.
Ishikawa H; Nakao K; Matsumoto K; Ichikawa T; Hamasaki K; Nakata K; Eguchi K
Hepatology; 2003 Mar; 37(3):696-704. PubMed ID: 12601367
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of tumor growth correlates with the expression level of a human angiostatin transgene in transfected B16F10 melanoma cells.
Ambs S; Dennis S; Fairman J; Wright M; Papkoff J
Cancer Res; 1999 Nov; 59(22):5773-7. PubMed ID: 10582698
[TBL] [Abstract][Full Text] [Related]
5. Angiostatin enhances B7.1-mediated cancer immunotherapy independently of effects on vascular endothelial growth factor expression.
Sun X; Kanwar JR; Leung E; Lehnert K; Wang D; Krissansen GW
Cancer Gene Ther; 2001 Oct; 8(10):719-27. PubMed ID: 11687895
[TBL] [Abstract][Full Text] [Related]
6. Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice.
Scappaticci FA; Smith R; Pathak A; Schloss D; Lum B; Cao Y; Johnson F; Engleman EG; Nolan GP
Mol Ther; 2001 Feb; 3(2):186-96. PubMed ID: 11237675
[TBL] [Abstract][Full Text] [Related]
7. Combined delivery of an antiangiogenic protein (angiostatin) and an immunomodulatory gene (interleukin-12) in the treatment of murine cancer.
Wilczyńska U; Kucharska A; Szary J; Szala S
Acta Biochim Pol; 2001; 48(4):1077-84. PubMed ID: 11995969
[TBL] [Abstract][Full Text] [Related]
8. A novel strategy for the tumor angiogenesis-targeted gene therapy: generation of angiostatin from endogenous plasminogen by protease gene transfer.
Matsuda KM; Madoiwa S; Hasumi Y; Kanazawa T; Saga Y; Kume A; Mano H; Ozawa K; Matsuda M
Cancer Gene Ther; 2000 Apr; 7(4):589-96. PubMed ID: 10811477
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of angiostatin, endostatin and interferon-alpha(1) gene transfer on in vivo growth of human breast cancer cells.
Indraccolo S; Gola E; Rosato A; Minuzzo S; Habeler W; Tisato V; Roni V; Esposito G; Morini M; Albini A; Noonan DM; Ferrantini M; Amadori A; Chieco-Bianchi L
Gene Ther; 2002 Jul; 9(13):867-78. PubMed ID: 12080381
[TBL] [Abstract][Full Text] [Related]
10. [Anti-tumor effect of eukaryotic expressing plasmid containing soluble tumor necrotic factor-related apoptosis inducing ligand combined with human angiostatin Kringle (1 - 3) genes on human gastric cancer xenografts in nude mice].
Sun W; Jiang Z; Xiang TX; Tao XH; Huang AL; Wang PL
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):841-5. PubMed ID: 19595126
[TBL] [Abstract][Full Text] [Related]
11. In vivo cytokine gene therapy of human tumor xenografts in SCID mice by liposome-mediated DNA delivery.
Egilmez NK; Cuenca R; Yokota SJ; Sorgi F; Bankert RB
Gene Ther; 1996 Jul; 3(7):607-14. PubMed ID: 8818648
[TBL] [Abstract][Full Text] [Related]
12. Mouse macrophage metalloelastase gene transfer into a murine melanoma suppresses primary tumor growth by halting angiogenesis.
Gorrin-Rivas MJ; Arii S; Furutani M; Mizumoto M; Mori A; Hanaki K; Maeda M; Furuyama H; Kondo Y; Imamura M
Clin Cancer Res; 2000 May; 6(5):1647-54. PubMed ID: 10815882
[TBL] [Abstract][Full Text] [Related]
13. [Inhibitory effects of murine angiostatin on implant carcinoma of nude mouse].
Tao K; Wu X; Dou K
Zhonghua Wai Ke Za Zhi; 2002 Aug; 40(8):621-4. PubMed ID: 12417081
[TBL] [Abstract][Full Text] [Related]
14. Effects of angiostatin gene transfer on functional properties and in vivo growth of Kaposi's sarcoma cells.
Indraccolo S; Morini M; Gola E; Carrozzino F; Habeler W; Minghelli S; Santi L; Chieco-Bianchi L; Cao Y; Albini A; Noonan DM
Cancer Res; 2001 Jul; 61(14):5441-6. PubMed ID: 11454689
[TBL] [Abstract][Full Text] [Related]
15. Angiostatin gene transfer as an effective treatment strategy in murine collagen-induced arthritis.
Kim JM; Ho SH; Park EJ; Hahn W; Cho H; Jeong JG; Lee YW; Kim S
Arthritis Rheum; 2002 Mar; 46(3):793-801. PubMed ID: 11920417
[TBL] [Abstract][Full Text] [Related]
16. A novel strategy for the generation of angiostatic kringle regions from a precursor derived from plasminogen.
Schmitz V; Wang L; Barajas M; Peng D; Prieto J; Qian C
Gene Ther; 2002 Dec; 9(23):1600-6. PubMed ID: 12424612
[TBL] [Abstract][Full Text] [Related]
17. [Human antisense-vascular endothelial growth factor gene therapy for laryngeal tumor by cationic liposome-mediated transfection].
Deng ZH; Jin M; Huang WG; Qiu JH; Liu SL; Wang JL
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Jan; 39(1):8-12. PubMed ID: 15127560
[TBL] [Abstract][Full Text] [Related]
18. Combined effects on tumor growth and metastasis by anti-estrogenic and antiangiogenic therapies in MMTV-neu mice.
Sacco MG; Soldati S; Mira Cató E; Cattaneo L; Pratesi G; Scanziani E; Vezzoni P
Gene Ther; 2002 Oct; 9(19):1338-41. PubMed ID: 12224018
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen kringle 5-engineered glioma cells block migration of tumor-associated macrophages and suppress tumor vascularization and progression.
Perri SR; Nalbantoglu J; Annabi B; Koty Z; Lejeune L; François M; Di Falco MR; Béliveau R; Galipeau J
Cancer Res; 2005 Sep; 65(18):8359-65. PubMed ID: 16166313
[TBL] [Abstract][Full Text] [Related]
20. Low dose adjuvant angiostatin decreases hepatic micrometastasis in murine ocular melanoma model.
Yang H; Akor C; Dithmar S; Grossniklaus HE
Mol Vis; 2004 Dec; 10():987-95. PubMed ID: 15623988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]